White House says U.S. fentanyl overdose programs will be funded 'in increments'

A panel of experts advising the U.S. Food and Drug Administration (FDA) is taking another look at the safety warnings tied to hormone replacement therapy (HRT) for menopause. The therapy, which helps ease symptoms like hot flashes, has been controversial for years due to links to increased risks of breast cancer and heart disease. Now, new research and evolving medical perspectives might lead to updated guidelines—potentially refining who should use HRT and for how long.

The latest health care market roundup dives into updates on big pharma players like Novartis and Johnson & Johnson, giving investors and industry watchers a snapshot of how these companies are performing and what trends might be shaping the sector. Think of it as a quick pulse check on who’s up, who’s down, and why it matters.

This summer, emergency rooms are seeing a surge in people seeking treatment for tick bites—especially in areas like upstate New York, where outdoor activities are booming. A camp doctor shares firsthand observations of the spike, hinting at possible factors like warmer weather or rising tick populations. Experts are urging caution (and bug spray) for anyone spending time outside.

Editor’s Note: Tick bites aren’t just itchy annoyances—they can carry serious diseases like Lyme. If more people are ending up in the ER, it’s a red flag that either ticks are getting worse, awareness is lagging, or both. For hikers, parents, and pet owners, this is a heads-up to double-check for ticks and know the warning signs.

A new report highlights stark disparities in NHS waiting times, with gynaecology patients facing some of the longest delays in England. The data underscores systemic imbalances in how healthcare resources are allocated, leaving many women stuck in limbo for essential care.

Editor’s Note: This isn’t just about long waits—it’s about who’s being left behind. When gynaecology services are consistently overwhelmed, it signals a deeper issue in prioritising women’s health. For patients, prolonged delays can mean worsening conditions, added stress, and even life-altering consequences. The story matters because it forces us to ask why some medical needs keep getting deprioritised, and what it’ll take to fix it.

Doctors are sounding the alarm as gastrointestinal cancers—like colorectal, stomach, and pancreatic—are surging in adults under 50. The trend is clear, but the reasons behind it remain a mystery, leaving experts scrambling for answers.

Editor’s Note: This isn’t just a medical curiosity—it’s a worrying shift that could reshape early screening guidelines and lifestyle recommendations. If you’re in your 30s or 40s, this hits close to home, especially since no one’s entirely sure what’s driving the spike. It’s a reminder that cancer isn’t just an "older person’s problem" anymore.